A biopharmaceutical company which develops breakthrough products that make a difference in patients' lives. It creates differentiated, innovative products by applying its platform technologies to established or novel medicines.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
On e plus side, NKTR has a solid and experienced management tean in place and a successful track record of developing products.
On the minus side, the new CEO is untried in the current situation and it remains to be seen if he can find the right strategy to guide NKTR out of the woods.
At under $6, NKTR has a lot of upside potential.